Você procurou por: dyremodeller (Dinamarquês - Inglês)

dyremodeller
animal models

i dyremodeller er samtidig
in animal models

prøve fra relevante dyremodeller
specimen from appropriate animal models

leflunomid er ikke antigent i dyremodeller.
leflunomide was not antigenic in animal models.

agomelatin resynkroniserer døgnrytmen i dyremodeller vedrørende døgnrytmeforstyrrelser.
agomelatine resynchronises circadian rhythms in animal models of circadian rhythm disruption.

rufinamid er aktivt i en række epilepsi-dyremodeller.
rufinamide is active in a range of animal models of epilepsy.

tacrolimussalve reducerede ikke hudtykkelsen og gav ikke hudatrofi i dyremodeller.
tacrolimus ointment did not reduce skin thickness and did not cause skin atrophy in animals.

der blev rapporteret kramper ved høje doser i dyremodeller (se pkt.
convulsions were reported at high doses in animal models (see section 5.3).

dyremodeller bekræfter, at ibandronsyre er en højpotent hæmmer af osteoklastaktiviteten.
animal models confirm that ibandronic acid is a highly potent inhibitor of osteoclastic activity.

i farmakologiske studier har calcitonin vist at have analgetisk aktivitet i dyremodeller.
in pharmacological studies, calcitonin has been shown to have analgesic activity in animal models.

i farmakologiske studier har calcitonin vist at have analgetisk ere aktivitet i dyremodeller.
by inhibiting osteoclast activity via its specific receptors, salmon calcitonin decreases bone resorption. ol in pharmacological studies, calcitonin has been shown to have analgesic activity in animal models.

lapatinib hæmmer erbb-drevet tumorcellevækst in vitro og i forskellige dyremodeller.
lapatinib inhibits erbb-driven tumour cell growth in vitro and in various animal models.

implementeringsforskning i kroniske immunmedierede sygdomme: bygge bro mellem dyremodeller og mennesker.
translational research in chronic immune-mediated disease: bridging between animal models and humans.

rosiglitazons antihyperglykæmiske aktivitet er påvist i et antal dyremodeller af type 2-diabetes.
the antihyperglycaemic activity of rosiglitazone has been demonstrated in a number of animal models of type 2 diabetes.

rosiglitazon forhindrede dertil udviklingen af udtalt hyperglykæmi i dyremodeller af type 2- diabetes.
in addition, rosiglitazone preserved ß-cell function as shown by increased pancreatic islet mass and insulin content and prevented the development of overt hyperglycaemia in animal models of type 2 diabetes.

aripiprazol viser antagonistiske egenskaber i dyremodeller med dopaminerg hyperaktivitet og agonistiske egenskaber i dyremodeller med dopaminerg hypoaktivitet.
aripiprazole exhibited antagonist properties in animal models of dopaminergic hyperactivity and agonist properties in animal models of dopaminergic hypoactivity.

ekstracellulær cgmp sænker smerte-fiber aktivitet, hvilket resulterer i reduceret visceral smerte i dyremodeller.
extracellular cgmp decreases pain-fiber activity, resulting in reduced visceral pain in animal models.

forbedret dyremodel
improved animal model